Comprehensive preclinical evaluation of second-generation miRNA-regulated Coxsackievirus B3-BHP: Potent antitumor efficacy and safety. [PDF]
Sakashita Y +9 more
europepmc +1 more source
EV-B 3D polymerase remodels viral populations through 5'UTR recombination to subvert cardiac antiviral innate immunity. [PDF]
Glenet M +6 more
europepmc +1 more source
Systemic removal of host restriction factors enables rapid, scalable virus production for cell culture-based vaccine development. [PDF]
Xu Z, Jeon J, Oh J, Shin Y, Park SH.
europepmc +1 more source
Suppression of Calpain Attenuates Coxsackievirus B3-Induced Myocarditis by Regulating RIPK1/RIPK3/MLKL Pathway. [PDF]
Liu Y +7 more
europepmc +1 more source
Hyperglycemia in Cats Infected by SARS-CoV-2: Pancreatic Alterations and Potential Antiviral Therapeutics. [PDF]
Onodera T, Seo S, Sakudo A, Toniolo A.
europepmc +1 more source
Hand, Foot, and Mouth Disease Surveillance in Anhui, After Introduction of the Enterovirus 71 Vaccine and During the COVID-19 Pandemic: Ecological Interrupted Time Series Study. [PDF]
Li K +8 more
europepmc +1 more source
Cardiomyopathy Caused by Coxsackievirus Strain A9 in Previously Healthy Child, Northeastern France, 2024. [PDF]
Lebreil AL +8 more
europepmc +1 more source
Genomic epidemiology of coxsackievirus A24 variant during the 2024 acute hemorrhagic conjunctivitis outbreak in Coastal Kenya. [PDF]
Morobe JM +13 more
europepmc +1 more source
Onychomadesis: A Rare Manifestation of Coxsackievirus A6 Infection in an Adult Patient. [PDF]
Panayiotou C +4 more
europepmc +1 more source

